Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083Mark A. Marzinke, Susan H. Eshleman, Ryan Kofron et al.|Antimicrobial Agents and Chemotherapy|2023Cited by 30
Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083Hannah P. Moore, Susan H. Eshleman, Jessica M. Fogel et al.|Open Forum Infectious Diseases|2025Cited by 0